The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy girls. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved approximately 800 older men with low testosterone and symptoms related to this ailment, including testosterone therapy side effects (see this here
) physical and sexual dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
The recent conflicting findings on testosterone therapy prompted Patel and his team to run a large systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in the United States suffer with low testosterone, which happens when the body fails to make enough hormones as a result of a difficulty with the testicles or pituitary gland. This clarifies decline of energy, obvious aging and an individual's sudden weight gain.
And many girls have a knee jerk feeling that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only does not raise a woman's risk of breast cancer
, it may play a vital role in warding off the disease. Glaser believes this will likely remain the status quo for some time, given the prohibitive cost of conducting the long term safety studies needed to win fuller FDA acceptance.